Genesystem Co., Ltd. (KOSDAQ:363250)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,250.00
+190.00 (4.68%)
At close: Sep 11, 2026

Genesystem Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Income
-10,282-11,955-8,915-7,915-8,996
Depreciation & Amortization
567.861,0181,242545.39386.3
Loss (Gain) From Sale of Assets
-133.55-50.18-3.14
Asset Writedown & Restructuring Costs
6,2756,275---
Loss (Gain) From Sale of Investments
-98.04-94.84-194.97-595.61380.34
Loss (Gain) on Equity Investments
----545.52444.93
Stock-Based Compensation
285.53223.3764.12106.8780.15
Provision & Write-off of Bad Debts
96.3612.0615.53-45.25303.51
Other Operating Activities
-1,957-2,021804.81,0882,252
Change in Accounts Receivable
-675.57-24.86100.38405.731,163
Change in Inventory
-138.79-60.27240.19-417.85-1,772
Change in Accounts Payable
-6.911.85-5.13-28.99-259.43
Change in Unearned Revenue
-12.09---35.0235.02
Change in Other Net Operating Assets
-2,205-261.92-689-373.46-438.07
Operating Cash Flow
-8,284-6,883-7,337-7,812-6,417
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Capital Expenditures
-521.75-219.66-258.73-362.85-238.43
Sale of Property, Plant & Equipment
16.950.55--
Cash Acquisitions
---56.11-
Sale (Purchase) of Intangibles
337.59-114.62-102.37-55.96-86.86
Investment in Securities
3,3303,0085,8391,274-2,260
Other Investing Activities
-212.7635.4294.063.2520.68
Investing Cash Flow
2,9502,7145,572-85.42-2,565

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Short-Term Debt Issued
-90---
Total Debt Issued
-90---
Long-Term Debt Repaid
--501.32-405.76-88.07-71.34
Net Debt Issued (Repaid)
-162.86-411.32-405.76-88.07-71.34
Issuance of Common Stock
6,15544.16211.57242.47224.33
Repurchase of Common Stock
---1,518--
Other Financing Activities
17.625.15-4.3124.0728.32
Financing Cash Flow
6,010-342.01-1,716178.48181.32

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Foreign Exchange Rate Adjustments
23.960.5514.15-28.686.32
Miscellaneous Cash Flow Adjustments
0-0-0
Net Cash Flow
699.86-4,511-3,467-7,747-8,794

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
-8,806-7,103-7,595-8,174-6,655
Free Cash Flow Growth
-----
Free Cash Flow Margin
-871.87%-1862.60%-628.89%-911.27%-182.18%
Free Cash Flow Per Share
-1215.08-1042.12-1109.26-1176.31-964.32
Levered Free Cash Flow
-5,703-3,972-1,423-8,402-
Unlevered Free Cash Flow
-5,628-3,894-1,338-8,319-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash Interest Paid
117.21121.66137.96133.9395.06
Cash Income Tax Paid
30.36-21.02-24.347.0164.87
Change in Working Capital
-3,039-335.2-353.55-449.58-1,272